Geron Co. (NASDAQ:GERN – Get Rating) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 25,860,000 shares, an increase of 5.1% from the February 28th total of 24,600,000 shares. Based on an average trading volume of 8,900,000 shares, the short-interest ratio is presently […]
Geron Co. (NASDAQ:GERN – Get Rating) shares were down 4.6% during trading on Tuesday . The company traded as low as $2.07 and last traded at $2.07. Approximately 618,815 shares changed hands during trading, a decline of 93% from the average daily volume of 8,903,256 shares. The stock had previously closed at $2.17. Wall Street […]
Equities research analysts at The Goldman Sachs Group initiated coverage on shares of Geron (NASDAQ:GERN – Get Rating) in a research note issued to investors on Monday, The Fly reports. The firm set a “neutral” rating on the biopharmaceutical company’s stock. Other research analysts also recently issued research reports about the company. Wedbush reiterated an […]